{"id":"W2006347360","doi":"10.1016/j.jval.2013.08.597","title":"A Prospective Time and Motion Analysis Comparing Intravenous (IV) Vesus Subcutaneous (SC) Bortezomib in Patients with Multiple Myeloma (MM)","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Bortezomib; Multiple myeloma; Premedication; Vial; Clinical trial; Surgery; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004132497,0.0003125384,0.0004678293,0.0006088869,0.0002662742,0.0005151537,0.000222321,0.0003696966,0.001583703],"category_scores_gemma":[0.001053515,0.0001679944,0.0006062872,0.0008280672,0.0001846854,0.0003363119,0.0004181536,0.0004119778,0.0002142915],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000392138,"about_ca_system_score_gemma":0.0003367306,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002556346,"about_ca_topic_score_gemma":0.002457517,"domain_scores_codex":[0.9997427,0.00007427939,0.00002984527,0.00006688247,0.00002614668,0.00006021906],"domain_scores_gemma":[0.9992994,0.0001609483,0.0002636785,0.00004883939,0.00007405495,0.0001530256],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03807633,0.0004434018,0.9422017,0.00006903437,0.0004580073,0.0001297141,0.0001060065,0.0004314468,0.003644162,0.00007715603,0.0001868139,0.01417637],"study_design_scores_gemma":[0.0007518984,0.009547194,0.9865688,0.00001416391,0.0004425079,0.000241055,0.0002479023,0.0009714821,0.0006561615,0.0000621107,0.0004811766,0.00001554833],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9990777,0.0003024371,0.0001132142,0.00001176531,0.000004489942,0.00001819622,0.0002254683,0.000002088095,0.0002446014],"genre_scores_gemma":[0.9991927,0.00007307,0.0001560302,0.00001790312,0.000008927942,0.00001831479,0.0003749672,0.000001457399,0.0001566494],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002556346,"threshold_uncertainty_score":0.005298018,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0170212104638445,"score_gpt":0.2620738018861646,"score_spread":0.2450525914223201,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}